Quarter Financials
Regencell Bioscience Holdings Limit... (RGC)
$26.9
-0.64 (-2.32%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2017 Q2
|
2017 Q1
|
2017 Q4
|
|---|
| Net Income | - | - | - | - | - | 29 | 11 | 24 |
|---|
| Dividend Paid | - | - | - | - | - | -35 | -35 | -35 |
|---|
| Retained Earnings | -11 | - | -4 | -3 | -3 | 71 | 76 | 99 |
|---|
|
Year
|
2022 Q4
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2017 Q2
|
2017 Q1
|
2017 Q4
|
|---|
| Capital Expenditure | - | - | - | - | - | -75 | -71 | -60 |
|---|
| Net PPE | 1 | - | 0 | 0 | 0 | 1,513 | 1,497 | 1,499 |
|---|
|
Year
|
2022 Q4
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2017 Q2
|
2017 Q1
|
2017 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | 354 | 346 | 346 | - | - | - | - | - |
|---|